Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: Evidence from 59,977 subjects

Breast Cancer Research and Treatment

Volumn 126, Issue 3, 2011, Pages 663-670

  Lu, Pei Hua ^a   Yang, Jie ^a   Li, Chen ^b   Wei, Mu Xin ^c   Shen, Wei ^a   Shi, Li Ping ^a   Jiang, Zhi Yang ^a   Zhou, Ning ^a   Tao, Guo Qing ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Genetic polymorphisms; Mitogen activated protein kinase kinase kinase 1 (MAP3K1); Mutation; Risk

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1;

ARTICLE; BREAST CANCER; CANCER RISK; CODOMINANCE; DOMINANT INHERITANCE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAP3K1 GENE; ONCOGENE; PENETRANCE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; BREAST NEOPLASMS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MAP KINASE KINASE KINASE 1; MIDDLE AGED; MODELS, STATISTICAL; ODDS RATIO; POLYMORPHISM, GENETIC; PROGNOSIS; RISK; SENSITIVITY AND SPECIFICITY;

EID: 79958739216     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1151-1     Document Type: Article

References (18)

1. Easton DF, Eeles RA (2008) Genome-wide association studies in cancer. Hum Mol Genet 17:R109-R115
2. Gail MH (2008) Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk. J Natl Cancer Inst 100:1037-1041 (Pubitemid 352019794)
3. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093 (Pubitemid 47014426)
4. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870-874 (Pubitemid 47014500)
5. Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 280:7460-7468 (Pubitemid 40349637)
6. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138:4030-4033 (Pubitemid 27351961)
7. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A et al (2006) Onco-genic pathway signatures in human cancers as a guide to targeted therapies. Nature 439:353-357 (Pubitemid 43128862)
8. Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D (2006) Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors. Cancer Res 66:3903-3911
9. Nordgard SH, Johansen FE, Alnaes GI, Naume B, Borresen-Dale AL, Kristensen VN (2007) Genes harbouring susceptibility SNPs are differentially expressed in the breast cancer subtypes. Breast Cancer Res 9:113
10. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI et al (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4:e1000054
11. Garcia-Closas M, Chanock S (2008) Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 14:8000-8009
12. Ahn NG (1993) The MAP kinase cascade. Discovery of a new signal transduction pathway. Mol Cell Biochem 127-128: 201-209 (Pubitemid 24032666)
13. Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, Black GC, Howell A, Evans DG, Newman WG (2010) Breast cancer susceptibility variants alter risks in familial disease. J Med Genet 47:126-131
14. Gorodnova TV, ESh K, Yanus GA, Katanugina AS, Abysheva SN, Togo AV, Imyanitov EN (2010) Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women. Cancer Genet Cytogenet 199:69-72
15. Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ, Millikan RC (2010) FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African American and younger women. Carcinogenesis 31(8):1417-1423
16. Tamimi RM, Lagiou P, Czene K, Liu J, Ekbom A, Hsieh CC, Adami HO, Trichopoulos D, Hall P (2010) Birth weight, breast cancer susceptibility loci, and breast cancer risk. Cancer Causes Control 21:689-696
17. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N et al (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82:937-948
18. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634 (Pubitemid 27387172)